BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 2467980)

  • 1. Lithium increases rat striatal beta- and gamma-preprotachykinin messenger RNAs.
    Sivam SP; Krause JE; Takeuchi K; Li S; McGinty JF; Hong JS
    J Pharmacol Exp Ther; 1989 Mar; 248(3):1297-301. PubMed ID: 2467980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopaminergic regulation of tachykinin metabolism in the striatonigral pathway.
    Li SJ; Sivam SP; McGinty JF; Huang YS; Hong JS
    J Pharmacol Exp Ther; 1987 Nov; 243(2):792-8. PubMed ID: 2445959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proenkephalin-A gene regulation in the rat striatum: influence of lithium and haloperidol.
    Sivam SP; Strunk C; Smith DR; Hong JS
    Mol Pharmacol; 1986 Aug; 30(2):186-91. PubMed ID: 3016502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of haloperidol and clozapine on preprotachykinin-A messenger RNA, tachykinin tissue levels, release and neurokinin-1 receptors in the striato-nigral system.
    Humpel C; Knaus GA; Auer B; Knaus HG; Haring C; Theodorsson E; Saria A
    Synapse; 1990; 6(1):1-9. PubMed ID: 1697986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lithium increases dynorphin A(1-8) and prodynorphin mRNA levels in the basal ganglia of rats.
    Sivam SP; Takeuchi K; Li S; Douglass J; Civelli O; Calvetta L; Herbert E; McGinty JF; Hong JS
    Brain Res; 1988 Apr; 427(2):155-63. PubMed ID: 2898269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of lithium and haloperidol administration on the rat brain levels of substance P.
    Hong JS; Tilson HA; Yoshikawa K
    J Pharmacol Exp Ther; 1983 Mar; 224(3):590-3. PubMed ID: 6186804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compensatory activation of substance P biosynthesis by L-dihydroxyphenylalanine in striatonigral neurons of neonatal dopaminergic denervated rats.
    Sivam SP; Krause JE
    J Pharmacol Exp Ther; 1990 Aug; 254(2):433-9. PubMed ID: 1696630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tachykinin gene expression in rat limbic nuclei: modulation by dopamine antagonists.
    Shibata K; Haverstick DM; Bannon MJ
    J Pharmacol Exp Ther; 1990 Oct; 255(1):388-92. PubMed ID: 1976801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine antagonist haloperidol decreases substance P, substance K, and preprotachykinin mRNAs in rat striatonigral neurons.
    Bannon MJ; Lee JM; Giraud P; Young A; Affolter HU; Bonner TI
    J Biol Chem; 1986 May; 261(15):6640-2. PubMed ID: 2422168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopaminergic regulation of striatonigral tachykinin and dynorphin gene expression: a study with the dopamine uptake inhibitor GBR-12909.
    Sivam SP
    Brain Res Mol Brain Res; 1996 Jan; 35(1-2):197-210. PubMed ID: 8717356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A role for tachykinins in female mouse and rat reproductive function.
    Pintado CO; Pinto FM; Pennefather JN; Hidalgo A; Baamonde A; Sanchez T; Candenas ML
    Biol Reprod; 2003 Sep; 69(3):940-6. PubMed ID: 12773411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Striatal tachykinin gene expression regulated by interaction of D-1 and D-2 dopamine receptors.
    Haverstick DM; Rubenstein A; Bannon MJ
    J Pharmacol Exp Ther; 1989 Feb; 248(2):858-62. PubMed ID: 2521903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of lithium on tachykinins, calcitonin gene-related peptide, and neuropeptide Y in rat brain.
    Mathé AA; Jousisto-Hanson J; Stenfors C; Theodorsson E
    J Neurosci Res; 1990 Jun; 26(2):233-7. PubMed ID: 2366266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Failure of MK-801 to suppress D1 receptor-mediated induction of locomotor activity and striatal preprotachykinin mRNA expression in the dopamine-depleted rat.
    Campbell BM; Kreipke CW; Walker PD
    Neuroscience; 2006; 137(2):505-17. PubMed ID: 16289829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of preprotachykinin-A and neuropeptide-Y messenger RNA in the thymus.
    Ericsson A; Geenen V; Robert F; Legros JJ; Vrindts-Gevaert Y; Franchimont P; Brene S; Persson H
    Mol Endocrinol; 1990 Aug; 4(8):1211-8. PubMed ID: 1705657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of risperidone and haloperidol on tachykinin and opioid precursor peptide mRNA levels in the caudate-putamen and nucleus accumbens of the rat.
    Mijnster MJ; Schotte A; Docter GJ; Voorn P
    Synapse; 1998 Apr; 28(4):302-12. PubMed ID: 9517839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gonadal steroid regulation of substance P (SP) and SP-encoding messenger ribonucleic acids in the rat anterior pituitary and hypothalamus.
    Brown ER; Harlan RE; Krause JE
    Endocrinology; 1990 Jan; 126(1):330-40. PubMed ID: 1688409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C/EBPbeta couples dopamine signalling to substance P precursor gene expression in striatal neurones.
    Kovács KA; Steinmann M; Magistretti PJ; Halfon O; Cardinaux JR
    J Neurochem; 2006 Sep; 98(5):1390-9. PubMed ID: 16771829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Partial reversal of increased preproenkephalin messenger ribonucleic acid (mRNA) and decreased preprotachykinin mRNA by foetal dopamine cells in unilateral 6-hydroxydopamine-lesioned rat striatum parallels functional recovery.
    Zeng BY; Jenner P; Marsden CD
    Mov Disord; 1996 Jan; 11(1):43-52. PubMed ID: 8771066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of the metabolism of striatal dynorphin by the dopaminergic system.
    Li SJ; Sivam SP; McGinty JF; Jiang HK; Douglass J; Calavetta L; Hong JS
    J Pharmacol Exp Ther; 1988 Jul; 246(1):403-8. PubMed ID: 2899169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.